Locally Advanced or Metastatic Solid Tumors

An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX-105 and INBRX-105 in Combination With Pembrolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Schedule an Appointment

Select an appointment date and time from available spots listed below.